Philips cuts 2026 sales growth forecast
Feb 10 - Dutch healthtech company Philips PHG.AS on Tuesday forecast comparable sales growth of 3% to 4.5% for 2026, below the roughly 4.5% expected previously. The company also said that it expects to generate free cash flow of between 1.3 billion and 1.5 billion euros. CEO Roy Jakobs said in December that the impact of U.S. tariffs was expected to "almost double" this year, pressuring margins despite ongoing cost cuts. (Reporting by Leo Marchandon in Gdansk) ((leo.marchandon@thomsonreuters.com))
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct